• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Missing link between metabolic syndrome and chronic kidney disease.?Role of asymmetric dimethylarginine-

Research Project

  • PDF
Project/Area Number 22590903
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKurume University

Principal Investigator

OKUDA Seiya  久留米大学, 医学部, 教授 (80158823)

Co-Investigator(Kenkyū-buntansha) UEDA Seiji  久留米大学, 医学部, 准教授 (80322593)
Project Period (FY) 2010 – 2012
Keywordsメタボリック症候群 / インスリン抵抗性 / 慢性腎臓病 / ADMA
Research Abstract

Metabolic syndrome (MetS) is a strong risk factor for the initiation and development of chronic kidney disease (CKD). One possible factor that could explain this link seems to be endothelial dysfunction (ED). In CKD patients, ADMA levels were associated with metabolic factors and eGFR. Further, increased ADMA levels were associated with surrogate markers for cardiovascular disease as well as annual reduction rates of GFR. Animal models of MetS revealed that dysregulation of DDAH, an enzyme for ADMA could account for ADMA elevation, and therefore could contributed to the development and progression of cardiovascular disease as well as renal injury in Mets.

  • Research Products

    (10 results)

All 2013 2012 2011 2010 2009 Other

All Journal Article (8 results) (of which Peer Reviewed: 8 results) Presentation (2 results)

  • [Journal Article] Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpressionin a rat model of nephrotic syndrome.2012

    • Author(s)
      Kaida Y, Ueda S, Yamagishi S, Nakayama Y, Ando R, Iwatani R, Fukami K, Okuda S.
    • Journal Title

      Life Sci.

      Volume: 91(9-10) Pages: 301-5

    • Peer Reviewed
  • [Journal Article] Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.2012

    • Author(s)
      Kajimoto H, Kai H, Aoki H, Yasuoka S, Anegawa T, Aoki Y, Ueda S, Okuda S, Imaizumi T
    • Journal Title

      Kidney Int.

      Volume: 81(8) Pages: 762-8

    • Peer Reviewed
  • [Journal Article] Association of asymmetric dimethylarginine with severity ofkidney injury and decline in kidney function in IgA nephropathy.2011

    • Author(s)
      Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S.
    • Journal Title

      Am J Nephrol.

      Volume: 33(1) Pages: 1-6

    • Peer Reviewed
  • [Journal Article] New pathways to renal damage: role of ADMA in retarding renal disease progression.2010

    • Author(s)
      Ueda S, Yamagishi S, Okuda S.
    • Journal Title

      J Nephrol.

      Volume: 23(4) Pages: 377-86

    • Peer Reviewed
  • [Journal Article] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a ratmodel of chronic kidney disease (CKD).2009

    • Author(s)
      Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
    • Journal Title

      Life Sci.

      Volume: 84(23-24) Pages: 853-6

    • Peer Reviewed
  • [Journal Article]2009

    • Author(s)
      Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
    • Journal Title

      Nephrol Dial Transplant.

      Volume: 24(4) Pages: 1162-9

    • Peer Reviewed
  • [Journal Article] Involvement of advanced glycation end product?induced asymmetric dimethylarginine generation in endothelial dysfunction.

    • Author(s)
      Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S.
    • Journal Title

      Diabetes & Vascular Disease Research.

    • Peer Reviewed
  • [Journal Article] Role of asymmetric dimetylarginine in cardiorenal syndrome.

    • Author(s)
      Ueda S, Yamagishi S, Yokoro M, Okuda S.
    • Journal Title

      Current Pharmaceutical Design

    • Peer Reviewed
  • [Presentation] MetSにおけるインスリン抵抗性発症についての検討-血管内皮障害因子ADMAの役割の解明-2013

    • Author(s)
      岩谷龍治、奥田誠也
    • Organizer
      第86回日本内分泌学会学術総会
    • Place of Presentation
      仙台
    • Year and Date
      2013-04-26
  • [Presentation] Involvement of DDAH-ADMA axis in accelerated renal injury in acute ischemia-reperfusion injury.2010

    • Author(s)
      Okuda S, et al.
    • Organizer
      American society of nephrology.
    • Place of Presentation
      Denver
    • Year and Date
      2010-11-19

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi